Polypeptides and uses thereof

Details for Australian Patent Application No. 2010299631 (hide)

Owner XImmune AB

Inventors Kalle, Martina; Malmsten, Nils Martin; Papareddy, Praveen; Rydengard, Victoria; Schmidtchen, Artur; Walse, Bjorn Ulrik

Agent Freehills

Pub. Number AU-A-2010299631

PCT Pub. Number WO2011/036445

Priority 0916578.8 22.09.09 GB

Filing date 22 September 2010

Wipo publication date 31 March 2011

International Classifications

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

Event Publications

3 May 2012 PCT application entered the National Phase

  PCT publication WO2011/036445 Priority application(s): WO2011/036445

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010299632-Encapsulated semiconductor nanoparticle - based materials comprising an additive

2010299630-Heparin cofactor II fragments with antiinflammatory and anti-coagulant activity